These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10983224)

  • 41. High drug costs seem to keep getting higher.
    Ackerman W
    J Ark Med Soc; 2005 Apr; 101(10):293. PubMed ID: 15839313
    [No Abstract]   [Full Text] [Related]  

  • 42. In Beltway, all eyes are on drug benefit.
    Gardner J
    Mod Healthc; 2000 May; 30(21):44. PubMed ID: 11067548
    [No Abstract]   [Full Text] [Related]  

  • 43. Controlling spending for prescription drugs.
    Altman SH; Parks-Thomas C
    N Engl J Med; 2002 Mar; 346(11):855-6. PubMed ID: 11893800
    [No Abstract]   [Full Text] [Related]  

  • 44. Need for integrated data in pharmacy benefits.
    Martens G; Clor GE
    J Health Care Benefits; 1993; 3(1):57-60. PubMed ID: 10130352
    [No Abstract]   [Full Text] [Related]  

  • 45. Prescription-drug coverage for medicare beneficiaries.
    Iglehart JK
    N Engl J Med; 2003 Sep; 349(10):923-5. PubMed ID: 12954738
    [No Abstract]   [Full Text] [Related]  

  • 46. Catastrophic health insurance: budget and policy issues.
    Helms RB
    Am J Pharm Educ; 1989; 53(4):356-9. PubMed ID: 10304253
    [No Abstract]   [Full Text] [Related]  

  • 47. Drugs, debates, deals, and deficits.
    Scott JS
    Healthc Financ Manage; 2002 Dec; 56(12):30, 33. PubMed ID: 12516156
    [No Abstract]   [Full Text] [Related]  

  • 48. Perspectives. What the drug benefit looks like now.
    Med Health; 2003 Nov; 57(43):1, 7-8. PubMed ID: 14723115
    [No Abstract]   [Full Text] [Related]  

  • 49. 1993 changes in drug cost for inpatient services.
    Mehl B
    Hosp Pharm; 1994 Aug; 29(8):771-3. PubMed ID: 10171916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The need for health care reform.
    Mossinghoff GJ
    Health Syst Rev; 1994; 27(3):5-6. PubMed ID: 10134516
    [No Abstract]   [Full Text] [Related]  

  • 51. Time to leave the capsule ... if you dare.
    McCarthy R
    Bus Health; 1991 Sep; 9(9):22-3, 26, 28 passim. PubMed ID: 10112859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Medicare prescription drug plan: assisting our older patients.
    Klein MN
    ORL Head Neck Nurs; 2004; 22(4):34-5. PubMed ID: 15617318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medicare & drugs: the elusive prize revisited.
    Iglehart JK
    Health Aff (Millwood); 2000; 19(2):6-7. PubMed ID: 10718017
    [No Abstract]   [Full Text] [Related]  

  • 54. Some over-the-counter advice on making drug therapy work. Interview by Patrick Mullen.
    Gans JA
    Manag Care; 2001 Oct; 10(10):41-2, 44, 47. PubMed ID: 11764745
    [No Abstract]   [Full Text] [Related]  

  • 55. Medicare/prescription drug benefit in the crossfire.
    Halamandaris VJ
    Caring; 2004 Jun; 23(6):56. PubMed ID: 15270333
    [No Abstract]   [Full Text] [Related]  

  • 56. Congressional healthcare outlook: prescription drugs.
    Graham SB
    Hosp Outlook; 2001 Jul; 4(5):6, 12. PubMed ID: 11478182
    [No Abstract]   [Full Text] [Related]  

  • 57. Prospective: Seniors confused, skeptical about Medicare changes.
    Med Health; 2004 Jun; 58(23):1, 7-8. PubMed ID: 15255406
    [No Abstract]   [Full Text] [Related]  

  • 58. Government commitment and regulation of prescription drugs.
    Frank RG
    Health Aff (Millwood); 2003; 22(3):46-8. PubMed ID: 12757271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expenditures for prescription drugs: too much or not enough?
    Schumock GT; Walton SM
    Healthc Financ Manage; 2003 Oct; 57(10):34-8, 41. PubMed ID: 14560578
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmaceutical prices continue to drive up supply costs.
    Hard R
    Hospitals; 1992 Mar; 66(5):49-50. PubMed ID: 1740289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.